The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 14, 2021

Filed:

Dec. 12, 2019
Applicant:

Aerie Pharmaceuticals, Inc., Bedminster, NJ (US);

Inventors:

Stuart Williams, Morrisville, NC (US);

Sanjib Kumar Das, Morrisville, NC (US);

Tomas Navratil, Morrisville, NC (US);

Melissa Sandahl, Morrisville, NC (US);

Janet Tully, Cary, NC (US);

Rozemarijn Verhoeven, Siler City, NC (US);

Assignee:

Aerie Pharmaceuticals, Inc., Bedminster, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/58 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 9/10 (2006.01); A61K 9/16 (2006.01); A61K 31/573 (2006.01); A61K 47/26 (2006.01); A61K 47/36 (2006.01); A61F 9/00 (2006.01); A61M 31/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/58 (2013.01); A61K 9/0048 (2013.01); A61K 9/0051 (2013.01); A61K 9/08 (2013.01); A61K 9/10 (2013.01); A61K 9/1647 (2013.01); A61K 31/573 (2013.01); A61K 47/26 (2013.01); A61K 47/36 (2013.01); A61F 9/0017 (2013.01); A61M 31/002 (2013.01);
Abstract

The disclosure teaches precisely engineered biodegradable drug delivery systems and methods of making and utilizing such systems. In aspects, the biodegradable drug delivery systems taught herein comprise intravitreal ocular implants suitable for delivery of corticosteroids to the posterior segment of a human eye. The intravitreal ocular implants described herein have a desired extended drug release profile suitable for treating inflammation of the human eye.


Find Patent Forward Citations

Loading…